- Filed
- May 15, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2023 · Mar 31, 2023 | $0 |
| Capex | Q1 2023 · Mar 31, 2022 | $96K |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $1.73B |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $1.55B |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $1.21B |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $1.57B |
| Total Assets | Q1 2023 · Mar 31, 2023 | $6.11B |
| Total Assets | Q1 2023 · Dec 31, 2022 | $5.65B |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 99.14M sh |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$701.8M |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | $0.11 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | $0.11 |
| Sga Expense | Q1 2023 · Mar 31, 2022 | $5.04M |
| Net Income | Q1 2023 · Mar 31, 2022 | $17.68M |
| Revenue | Q1 2023 · Mar 31, 2022 | $63.03M |